References
Hobeika C, Cauchy F, Pote N et al (2019) Short- and long-term outcomes of liver resection for intrahepatic Cholangiocarcinoma associated with the metabolic syndrome. World J Surg 43:2048–2060. https://doi.org/10.1007/s00268-019-04996
D'Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281
Hoekstra LT, de Graaf W, Nibourg GA et al (2013) Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg 257:27–36
Mavros MN, Economopoulos KP, Alexiou VG et al (2014) Treatment and prognosis for patients with intrahepatic Cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149:565–574
Vigano L, Lleo A, Aghemo A (2018) Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario. Hepatobiliary Surg Nutr 7:130–133
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Xu, G., Zhou, XX., Xu, WY. et al. Letter to the Editor: Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome. World J Surg 44, 1002–1003 (2020). https://doi.org/10.1007/s00268-019-05318-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-019-05318-y